InvoCare Limited Logo

InvoCare Limited

IVC.AX

(1.0)
Stock Price

12,67 AUD

1.31% ROA

3.29% ROE

93.66x PER

Market Cap.

1.810.644.360,00 AUD

37.84% DER

4.74% Yield

3.31% NPM

InvoCare Limited Stock Analysis

InvoCare Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

InvoCare Limited Fundamental Stock Analysis
# Analysis Rating
1 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

2 DER

The stock maintains a fair debt to equity ratio (70%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (8.058) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

4 ROE

The stock's ROE indicates a negative return (-0.31%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-0.11%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 PBV

The stock's elevated P/BV ratio (3.12x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

InvoCare Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

InvoCare Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

InvoCare Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

InvoCare Limited Revenue
Year Revenue Growth
2001 126.089.000
2003 140.287.000 10.12%
2004 148.292.000 5.4%
2005 149.393.000 0.74%
2006 161.070.000 7.25%
2007 224.912.000 28.39%
2008 245.238.000 8.29%
2009 258.606.000 5.17%
2010 268.596.000 3.72%
2011 321.113.000 16.35%
2012 368.652.000 12.9%
2013 385.352.000 4.33%
2014 413.011.000 6.7%
2015 436.371.000 5.35%
2016 450.659.000 3.17%
2017 456.915.000 1.37%
2018 477.703.000 4.35%
2019 494.584.000 3.41%
2019 494.584.000 0%
2020 471.617.000 -4.87%
2021 529.359.000 10.91%
2022 588.933.000 10.12%
2023 560.358.000 -5.1%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

InvoCare Limited Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 23.862.000 100%
2021 18.925.000 -26.09%
2022 31.786.000 40.46%
2023 39.786.000 20.11%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

InvoCare Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2003 60.330.000 100%
2004 63.945.000 5.65%
2005 65.361.000 2.17%
2006 70.876.000 7.78%
2007 79.997.000 11.4%
2008 87.979.000 9.07%
2009 94.472.000 6.87%
2010 98.209.000 3.81%
2011 118.447.000 17.09%
2012 136.338.000 13.12%
2013 145.489.000 6.29%
2014 156.531.000 7.05%
2015 170.486.000 8.19%
2016 179.212.000 4.87%
2017 182.205.000 1.64%
2018 192.337.000 5.27%
2019 187.141.000 -2.78%
2019 187.141.000 0%
2020 197.297.000 5.15%
2021 220.047.000 10.34%
2022 249.744.000 11.89%
2023 39.786.000 -527.72%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

InvoCare Limited EBITDA
Year EBITDA Growth
2001 126.089.000
2003 46.729.000 -169.83%
2004 48.996.000 4.63%
2005 46.149.000 -6.17%
2006 50.116.000 7.92%
2007 60.406.000 17.03%
2008 62.161.000 2.82%
2009 65.579.000 5.21%
2010 60.043.000 -9.22%
2011 65.883.000 8.86%
2012 93.537.000 29.56%
2013 99.455.000 5.95%
2014 111.340.000 10.67%
2015 113.917.000 2.26%
2016 135.416.000 15.88%
2017 186.127.000 27.25%
2018 104.819.000 -77.57%
2019 154.934.000 32.35%
2019 177.122.000 12.53%
2020 74.844.000 -136.65%
2021 159.576.000 53.1%
2022 55.952.000 -185.2%
2023 68.396.000 18.19%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

InvoCare Limited Gross Profit
Year Gross Profit Growth
2001 126.089.000
2003 119.104.000 -5.86%
2004 125.904.000 5.4%
2005 127.744.000 1.44%
2006 138.098.000 7.5%
2007 160.277.000 13.84%
2008 172.130.000 6.89%
2009 183.104.000 5.99%
2010 192.345.000 4.8%
2011 225.721.000 14.79%
2012 261.348.000 13.63%
2013 272.125.000 3.96%
2014 291.397.000 6.61%
2015 310.926.000 6.28%
2016 323.634.000 3.93%
2017 332.511.000 2.67%
2018 353.311.000 5.89%
2019 369.518.000 4.39%
2019 369.518.000 0%
2020 351.103.000 -5.24%
2021 400.532.000 12.34%
2022 439.980.000 8.97%
2023 420.466.000 -4.64%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

InvoCare Limited Net Profit
Year Net Profit Growth
2001 0
2003 -45.000 100%
2004 -57.000 21.05%
2005 20.141.000 100.28%
2006 24.047.000 16.24%
2007 27.554.000 12.73%
2008 28.026.000 1.68%
2009 33.198.000 15.58%
2010 27.366.000 -21.31%
2011 27.012.000 -1.31%
2012 44.479.000 39.27%
2013 48.869.000 8.98%
2014 54.515.000 10.36%
2015 54.844.000 0.6%
2016 70.949.000 22.7%
2017 97.439.000 27.19%
2018 41.224.000 -136.36%
2019 63.888.000 35.47%
2019 63.752.000 -0.21%
2020 -9.075.000 802.5%
2021 80.158.000 111.32%
2022 -1.714.000 4776.66%
2023 8.918.000 119.22%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

InvoCare Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 0 0%
2019 1 0%
2019 1 0%
2020 0 0%
2021 1 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

InvoCare Limited Free Cashflow
Year Free Cashflow Growth
2003 -6.054.000
2004 -4.011.000 -50.93%
2005 -6.904.000 41.9%
2006 -9.817.000 29.67%
2007 -17.366.000 43.47%
2008 -16.359.000 -6.16%
2009 -13.846.000 -18.15%
2010 -14.266.000 2.94%
2011 -16.723.000 14.69%
2012 -18.412.000 9.17%
2013 -19.264.000 4.42%
2014 -26.665.000 27.76%
2015 -22.035.000 -21.01%
2016 -30.321.000 27.33%
2017 -47.471.000 36.13%
2018 -35.812.000 -32.56%
2019 -16.322.250 -119.41%
2019 -1.459.000 -1018.73%
2020 -4.568.000 68.06%
2021 15.037.000 130.38%
2022 -15.436.000 197.42%
2023 -15.616.500 1.16%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

InvoCare Limited Operating Cashflow
Year Operating Cashflow Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 48.308.000 100%
2019 0 0%
2019 63.830.000 100%
2020 63.568.000 -0.41%
2021 77.740.000 18.23%
2022 47.912.000 -62.26%
2023 -2.784.000 1820.98%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

InvoCare Limited Capital Expenditure
Year Capital Expenditure Growth
2003 6.054.000
2004 4.011.000 -50.93%
2005 6.904.000 41.9%
2006 9.817.000 29.67%
2007 17.366.000 43.47%
2008 16.359.000 -6.16%
2009 13.846.000 -18.15%
2010 14.266.000 2.94%
2011 16.723.000 14.69%
2012 18.412.000 9.17%
2013 19.264.000 4.42%
2014 26.665.000 27.76%
2015 22.035.000 -21.01%
2016 30.321.000 27.33%
2017 47.471.000 36.13%
2018 84.120.000 43.57%
2019 16.322.250 -415.37%
2019 65.289.000 75%
2020 68.136.000 4.18%
2021 62.703.000 -8.66%
2022 63.348.000 1.02%
2023 12.832.500 -393.65%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

InvoCare Limited Equity
Year Equity Growth
2001 0
2003 64.114.000 100%
2004 75.674.000 15.28%
2005 27.461.000 -175.57%
2006 46.360.000 40.77%
2007 60.479.000 23.35%
2008 62.979.000 3.97%
2009 77.465.000 18.7%
2010 97.423.000 20.49%
2011 142.617.000 31.69%
2012 151.891.000 6.11%
2013 170.697.000 11.02%
2014 187.959.000 9.18%
2015 203.438.000 7.61%
2016 234.210.000 13.14%
2017 282.417.000 17.07%
2018 174.685.000 -61.67%
2019 296.979.000 41.18%
2020 531.900.000 44.17%
2021 580.921.000 8.44%
2022 545.216.000 -6.55%
2023 638.094.000 14.56%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

InvoCare Limited Assets
Year Assets Growth
2001 0
2003 291.067.000 100%
2004 279.033.000 -4.31%
2005 279.304.000 0.1%
2006 309.714.000 9.82%
2007 332.369.000 6.82%
2008 340.380.000 2.35%
2009 341.895.000 0.44%
2010 635.457.000 46.2%
2011 806.417.000 21.2%
2012 862.150.000 6.46%
2013 916.567.000 5.94%
2014 965.253.000 5.04%
2015 1.008.609.000 4.3%
2016 1.085.191.000 7.06%
2017 1.184.561.000 8.39%
2018 1.341.999.000 11.73%
2019 1.600.763.000 16.17%
2020 1.755.341.000 8.81%
2021 1.757.114.000 0.1%
2022 1.737.238.000 -1.14%
2023 1.717.330.000 -1.16%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

InvoCare Limited Liabilities
Year Liabilities Growth
2001 0
2003 226.953.000 100%
2004 203.359.000 -11.6%
2005 251.843.000 19.25%
2006 263.354.000 4.37%
2007 271.890.000 3.14%
2008 277.401.000 1.99%
2009 264.430.000 -4.91%
2010 538.034.000 50.85%
2011 663.800.000 18.95%
2012 710.259.000 6.54%
2013 745.870.000 4.77%
2014 777.294.000 4.04%
2015 805.171.000 3.46%
2016 850.981.000 5.38%
2017 902.144.000 5.67%
2018 1.167.314.000 22.72%
2019 1.303.784.000 10.47%
2020 1.223.441.000 -6.57%
2021 1.176.193.000 -4.02%
2022 1.192.022.000 1.33%
2023 1.079.236.000 -10.45%

InvoCare Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.09
Net Income per Share
0.14
Price to Earning Ratio
93.66x
Price To Sales Ratio
3.09x
POCF Ratio
47.49
PFCF Ratio
-55.99
Price to Book Ratio
2.86
EV to Sales
3.05
EV Over EBITDA
22.74
EV to Operating CashFlow
46.71
EV to FreeCashFlow
-55.31
Earnings Yield
0.01
FreeCashFlow Yield
-0.02
Market Cap
1,81 Bil.
Enterprise Value
1,79 Bil.
Graham Number
3.67
Graham NetNet
-6.94

Income Statement Metrics

Net Income per Share
0.14
Income Quality
1.97
ROE
0.03
Return On Assets
0.01
Return On Capital Employed
0.03
Net Income per EBT
0.71
EBT Per Ebit
0.58
Ebit per Revenue
0.08
Effective Tax Rate
0.29

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.75
Operating Profit Margin
0.08
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.05
Dividend Yield %
4.74
Payout Ratio
1.81
Dividend Per Share
0.6

Operating Metrics

Operating Cashflow per Share
0.27
Free CashFlow per Share
-0.23
Capex to Operating CashFlow
-1.84
Capex to Revenue
-0.12
Capex to Depreciation
-1.39
Return on Invested Capital
0.04
Return on Tangible Assets
0.01
Days Sales Outstanding
31.19
Days Payables Outstanding
118.48
Days of Inventory on Hand
119.71
Receivables Turnover
11.7
Payables Turnover
3.08
Inventory Turnover
3.05
Capex per Share
-0.49

Balance Sheet

Cash per Share
0,15
Book Value per Share
4,44
Tangible Book Value per Share
2.81
Shareholders Equity per Share
4.44
Interest Debt per Share
1.68
Debt to Equity
0.38
Debt to Assets
0.14
Net Debt to EBITDA
-0.28
Current Ratio
1.39
Tangible Asset Value
0,40 Bil.
Net Current Asset Value
-0,89 Bil.
Invested Capital
0.38
Working Capital
0,05 Bil.
Intangibles to Total Assets
0.14
Average Receivables
0,05 Bil.
Average Payables
0,05 Bil.
Average Inventory
48660000
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

InvoCare Limited Dividends
Year Dividends Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 1 0%

InvoCare Limited Profile

About InvoCare Limited

InvoCare Limited provides funeral, cemetery, crematoria, and related services in Australia, New Zealand, and Singapore. The company operates approximately 290 funeral home locations, and 17 cemeteries and crematoria that offers burial, memorial parks, and cremation services. It also offers pet cremation services under the Patch & Purr, Pets in Peace, Family Pet Care, and the Lanswood and Edenhill brands; and LifeArt coffins. In addition, the company operates MyGriefAssist, an online grief resource website; and MyMemorial, a website that provides range of cremation and burial memorial options. Further, it offers digital funeral services under the Funeral Planner brand name; and Guardian Plan, a prepaid funeral plan. InvoCare Limited was incorporated in 2001 and is headquartered in North Sydney, Australia.

CEO
Mr. Olivier J. Chretien M.B.A.
Employee
2.000
Address
40 Mount Street
North Sydney, 2060

InvoCare Limited Executives & BODs

InvoCare Limited Executives & BODs
# Name Age
1 Mr. Fergus Kelly
Chief Marketing Officer
70
2 Mr. Phillip Friery BBus, C.A.
Advisor
70
3 Ms. Heidi Aldred BECON, L.L.B.
Company Secretary & Corporate Counsel
70
4 Ms. Amanda Tober
Group Executive of Human Resources
70
5 Ms. Grace Westdorp
Executive General Manager of Health, Safety & Sustainability
70
6 Mr. Olivier J. Chretien M.B.A.
MD, Chief Executive Officer & Director
70
7 Mr. Adrian Gratwicke C.A., B.A., M.B.A., CA, Exec MBA, BA (Hons), GAICD
Chief Financial Officer
70
8 Mr. Phillip Friery BBus, C.A., CA
Advisor
70
9 Mr. Adrian Gratwicke B.A., BA (Hons), C.A., CA, Exec MBA, GAICD, M.B.A.
Chief Financial Officer
70
10 Mr. Graeme Rhind
Chairman of New Zealand
70
11 Ms. Victoria Doidge
Chief Customer Officer
70
12 Mr. Adrian Gratwicke B.A., BA (Hons), C.A., Exec MBA, GAICD, M.B.A.
Chief Financial Officer
70

InvoCare Limited Competitors

Iress Limited Logo
Iress Limited

IRE.AX

(1.8)
GUD Holdings Limited Logo
GUD Holdings Limited

GUD.AX

(2.0)
Challenger Limited Logo
Challenger Limited

CGF.AX

(2.5)
Ansell Limited Logo
Ansell Limited

ANN.AX

(2.2)